171 related articles for article (PubMed ID: 28728208)
1. The Role of 18F-FDG PET/CT Scan in Predicting Histological Type of Thymic Epithelial Tumors: Indications and Practical Clinical Considerations.
Lococo F
Thorac Cardiovasc Surg; 2018 Jun; 66(4):350-351. PubMed ID: 28728208
[No Abstract] [Full Text] [Related]
2. Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review.
Sharma P; Singhal A; Kumar A; Bal C; Malhotra A; Kumar R
Acta Radiol; 2013 Feb; 54(1):14-21. PubMed ID: 23377872
[TBL] [Abstract][Full Text] [Related]
3. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
[TBL] [Abstract][Full Text] [Related]
4. Re: Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
Priola AM; Veltri A; Priola SM
Clin Nucl Med; 2016 Sep; 41(9):748. PubMed ID: 27405030
[No Abstract] [Full Text] [Related]
5. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S
Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323
[TBL] [Abstract][Full Text] [Related]
6. Reply to Bertolaccini et al.
Fukumoto K; Yokoi K
Eur J Cardiothorac Surg; 2013 Jul; 44(1):188-9. PubMed ID: 23341042
[No Abstract] [Full Text] [Related]
7. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
[TBL] [Abstract][Full Text] [Related]
8. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
[TBL] [Abstract][Full Text] [Related]
9. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J
Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of metabolic response with
Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
[TBL] [Abstract][Full Text] [Related]
11. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
Liu Y
Nucl Med Commun; 2011 Jul; 32(7):554-62. PubMed ID: 21403583
[TBL] [Abstract][Full Text] [Related]
12. The utility of FDG-PET in the diagnosis of thymic epithelial tumors.
Otsuka H
J Med Invest; 2012; 59(3-4):225-34. PubMed ID: 23037192
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
14. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
[TBL] [Abstract][Full Text] [Related]
15. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
Viti A; Terzi A; Bianchi A; Bertolaccini L
Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467
[TBL] [Abstract][Full Text] [Related]
16. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms.
Shinya T; Tanaka T; Soh J; Matsushita T; Sato S; Toyooka S; Yoshino T; Miyoshi S; Kanazawa S
Acta Med Okayama; 2017 Apr; 71(2):105-112. PubMed ID: 28420891
[TBL] [Abstract][Full Text] [Related]
18. Correlation sometimes implies causation: possible roles of correlation analysis between 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography and thymic epithelial neoplasms.
Bertolaccini L; Viti A; Cavallo A; Terzi A
Eur J Cardiothorac Surg; 2013 Jul; 44(1):187-8. PubMed ID: 23337328
[No Abstract] [Full Text] [Related]
19. Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
Lee G; I H; Kim SJ; Pak K; Cho JS; Jeong YJ; Lee CH; Chang S
Clin Nucl Med; 2016 Jan; 41(1):8-14. PubMed ID: 26284773
[TBL] [Abstract][Full Text] [Related]
20. Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?
Lococo F; Cesario A; Treglia G
Ann Nucl Med; 2014 Jul; 28(6):593-4. PubMed ID: 24728730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
